Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × Phantoms, Imaging × Clear all

Sponsor

Conditions

Wilms Tumor 4 Rhabdoid Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Neuroblastoma 4 Medulloblastoma 4 Lymphoma, Non-Hodgkin 4 Histiocytosis, Langerhans-Cell 4 Hepatoblastoma 4 Glioma 4 Ependymoma 4 Sarcoma 3 Rhabdomyosarcoma 3 Osteosarcoma 3 Central Nervous System Neoplasms 3 Sarcoma, Ewing 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuroendocrine Tumors 2 Lung Neoplasms 2 Burkitt Lymphoma 2 Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1 Non functioning pancreatic endocrine tumor 1 Neoplasm Metastasis 1 Lymphoma, B-Cell 1 Lymphoma 1 Familial ependymoma 1 Carcinoma, Non-Small-Cell Lung 1 Adenoma, Islet Cell 1

Interventions

Paclitaxel 33 pembrolizumab 30 Carboplatin 28 Cyclophosphamide 18 Albumin-Bound Paclitaxel 18 Taxes 15 130-nm albumin-bound paclitaxel 15 Doxorubicin 14 atezolizumab 13 Capecitabine 13 Cisplatin 11 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 talazoparib 5 durvalumab 5 Everolimus 5 Biopsy 5 Bevacizumab 5 spartalizumab 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 sacituzumab govitecan 3 entinostat 3 bintrafusp alfa protein, human 3 Trastuzumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡